In AD mice, catalpol could significantly increase the activity of SOD, GSH-Px, and CAT and reduce the levels of soluble Aβ40 and Aβ42 in the cerebral cortex of the hippocampus, thus inhibiting the formation of senile plaques. The gene discussed is CAT; the disease is Alzheimer disease.